Abstract

This Small Business Innovation Research (SBIR) Phase I project proposes to develop methods to use Sublancin 168 for detection, inactivation and decontamination of Bacillus spores.

The commercial application of this project will be in the area of detection and control of Bacillus anthracis, the causative agent of anthrax.

  Funding Agency

Agency
National Science Foundation (NSF)
Institute
Division of Industrial Innovation and Partnerships (IIP)
Type
Standard Grant (Standard)
Application #
0419114
Program Officer
Om P. Sahai
Project Start
Project End
Budget Start
2004-07-01
Budget End
2004-12-31
Support Year
Fiscal Year
2004
Total Cost
$97,928
Indirect Cost

  Institution

Name
Sun Biomedical Technologies, Inc
Department
Type
DUNS #
City
Ridgecrest
State
CA
Country
United States
Zip Code
93555